The Claim
Six weeks of daily omega-3 fatty acid supplementation (510 mg EPA + 200 mg DHA) in patients with advanced non-small cell lung cancer has no significant effect on body weight, mid-upper arm circumference, fat-free mass, or quality of life as measured by the EORTC QLQ-C30.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with advanced non-small cell lung cancer, taking omega-3 fatty acid supplements daily for six weeks does not change body weight, muscle mass, arm circumference, or self-reported quality of life.
See the scientific wording
In patients with advanced non-small cell lung cancer, six weeks of daily omega-3 fatty acid supplementation (510 mg EPA + 200 mg DHA) shows no significant effect on body weight, mid-upper arm circumference, fat-free mass, or quality of life as measured by the EORTC QLQ-C30, indicating no measurable improvement in nutritional status or patient-reported well-being during this period.
Omega-3 fatty acids enter the body and change how immune cells make inflammatory signals, which lowers certain inflammation markers in the blood. But this reduction does not change how the body breaks down or builds muscle, nor does it affect how much energy the body uses or how the patient feels day-to-day.
What the research says
1 studyThe study gave lung cancer patients omega-3 pills for six weeks and found their weight, muscle, and how they felt day-to-day didn’t get better — just like the claim says. The pills did lower some inflammation markers, but that’s not what the claim is about.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.